Details for New Drug Application (NDA): 212932
✉ Email this page to a colleague
The generic ingredient in EPHEDRINE SULFATE is ephedrine sulfate. There are sixty-eight drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the ephedrine sulfate profile page.
Summary for 212932
Tradename: | EPHEDRINE SULFATE |
Applicant: | Amneal |
Ingredient: | ephedrine sulfate |
Patents: | 0 |
Pharmacology for NDA: 212932
Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
Physiological Effect | Increased Norepinephrine Activity |
Medical Subject Heading (MeSH) Categories for 212932
Suppliers and Packaging for NDA: 212932
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
EPHEDRINE SULFATE | ephedrine sulfate | SOLUTION;INTRAVENOUS | 212932 | ANDA | NorthStar Rx LLC | 16714-037 | 16714-037-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (16714-037-10) / 1 mL in 1 VIAL, SINGLE-DOSE (16714-037-01) |
EPHEDRINE SULFATE | ephedrine sulfate | SOLUTION;INTRAVENOUS | 212932 | ANDA | Amneal Pharmaceuticals LLC | 70121-1637 | 70121-1637-5 | 25 VIAL, SINGLE-DOSE in 1 CARTON (70121-1637-5) / 1 mL in 1 VIAL, SINGLE-DOSE (70121-1637-1) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 50MG/ML (50MG/ML) | ||||
Approval Date: | Oct 23, 2019 | TE: | AP | RLD: | No |
Complete Access Available with Subscription